Guardant Health, Inc. (GH)
NASDAQ: GH · Real-Time Price · USD
65.26
-0.06 (-0.09%)
Oct 9, 2025, 4:00 PM EDT - Market closed
Guardant Health Market Cap
Guardant Health has a market cap or net worth of $8.14 billion as of October 10, 2025. Its market cap has increased by 193.23% in one year.
Market Cap
8.14B
Enterprise Value
8.95B
1-Year Change
193.23%
Ranking
Category
Stock Price
$65.26
Market Cap Chart
Since October 4, 2018, Guardant Health's market cap has increased from $2.69B to $8.14B, an increase of 202.48%. That is a compound annual growth rate of 17.08%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Oct 9, 2025 | 8.14B | 115.61% |
| Dec 31, 2024 | 3.77B | 14.96% |
| Dec 29, 2023 | 3.28B | 17.84% |
| Dec 30, 2022 | 2.79B | -72.60% |
| Dec 31, 2021 | 10.17B | -21.09% |
| Dec 31, 2020 | 12.88B | 75.59% |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro |
| Oct 4, 2018 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Eli Lilly and Company | 767.88B |
| Johnson & Johnson | 460.19B |
| AbbVie | 407.53B |
| UnitedHealth Group | 333.01B |
| AstraZeneca | 266.87B |
| Novo Nordisk | 261.06B |
| Novartis AG | 256.06B |
| Abbott Laboratories | 232.02B |